YLT-11
Product Specifications
Target
Apoptosis|||PLK|||Others
Related Pathways
Apoptosis|||Others|||Cell Cycle/Checkpoint
Bioactivity
YLT-11 is a potent, selective, and orally active inhibitor of polo-like kinase 4 (PLK4), with dissociation constant (Kd) values of >10000 nM for PLK1, 653 nM for PLK2, >10000 nM for PLK3, and 5.2 nM for PLK4. It demonstrates antiproliferative effects, induces apoptosis, and causes cell cycle arrest at the G2/M phase, highlighting its anticancer activity.
Smiles
CC(=O)NC1=NC=CC(=N1)C2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=C(C=C4)CN(C)C
Molecular Formula
C24H24N6O
Molecular Weight
412.49
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/62151386460061740/T73471
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal SPNS1 Antibody [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/genprice5.png)
![ESE1 (ELF3) Mouse Monoclonal Antibody [Clone:6G6]](https://cdn.genprice.uk/genprice/genprice2.png)
MP1368J Each
Magic™ Membrane Protein Human KCNJ1 (Potassium inwardly rectifying channel subfamily J member 1) expressed in Yeast for Antibody Discovery
Ask
View Details